Stephen Holleran
Overview
Explore the profile of Stephen Holleran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wynn C, Catallozzi M, Kolff C, Holleran S, Meyer D, Ramakrishnan R, et al.
JMIR Mhealth Uhealth
. 2021 Dec;
9(12):e26356.
PMID: 34958306
Background: Completion rates among adolescents who initiate the human papillomavirus (HPV) vaccine 3-dose series are low. SMS text message vaccine reminders are effective, but less is known about the best...
2.
Stephens A, Wynn C, Hofstetter A, Kolff C, Pena O, Kahn E, et al.
Appl Clin Inform
. 2021 Dec;
12(5):1101-1109.
PMID: 34911126
Background: Immunization reminders in electronic health records (EHR) provide clinical decision support (CDS) that can reduce missed immunization opportunities. Little is known about using CDS rules from a regional immunization...
3.
Reyes-Soffer G, Sztalryd C, Horenstein R, Holleran S, Matveyenko A, Thomas T, et al.
Arterioscler Thromb Vasc Biol
. 2018 Dec;
39(1):63-72.
PMID: 30580564
Objective- Apo (apolipoprotein) CIII inhibits lipoprotein lipase (LpL)-mediated lipolysis of VLDL (very-low-density lipoprotein) triglyceride (TG) and decreases hepatic uptake of VLDL remnants. The discovery that 5% of Lancaster Old Order...
4.
Nandakumar R, Matveyenko A, Thomas T, Pavlyha M, Ngai C, Holleran S, et al.
J Lipid Res
. 2018 Oct;
59(12):2397-2402.
PMID: 30293969
Elevated lipoprotein (a) [Lp(a)] levels increase the risk for CVD. Novel treatments that decrease LDL cholesterol (LDL-C) have also shown promise for reducing Lp(a) levels. Mipomersen, an antisense oligonucleotide that...
5.
Thomas T, Zhou H, Karmally W, Ramakrishnan R, Holleran S, Liu Y, et al.
Arterioscler Thromb Vasc Biol
. 2017 Jul;
37(9):1770-1775.
PMID: 28729361
Objective: Lp(a) [lipoprotein (a)] is composed of apoB (apolipoprotein B) and apo(a) [apolipoprotein (a)] and is an independent risk factor for cardiovascular disease and aortic stenosis. In clinical trials, anacetrapib,...
6.
Millar J, Lassman M, Thomas T, Ramakrishnan R, Jumes P, Dunbar R, et al.
J Lipid Res
. 2017 Mar;
58(6):1214-1220.
PMID: 28314859
Cholesteryl ester transfer protein (CETP) mediates the transfer of HDL cholesteryl esters for triglyceride (TG) in VLDL/LDL. CETP inhibition, with anacetrapib, increases HDL-cholesterol, reduces LDL-cholesterol, and lowers TG levels. This...
7.
Reyes-Soffer G, Pavlyha M, Ngai C, Thomas T, Holleran S, Ramakrishnan R, et al.
Circulation
. 2016 Dec;
135(4):352-362.
PMID: 27986651
Background: Alirocumab, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9), lowers plasma low-density lipoprotein (LDL) cholesterol and apolipoprotein B100 (apoB). Although studies in mice and cells have identified...
8.
Stockwell M, Natarajan K, Ramakrishnan R, Holleran S, Forney K, Aponte A, et al.
Pediatrics
. 2016 Jun;
137(6).
PMID: 27244856
Objective: To assess the impact of exchange of immunization information between an immunization information system (IIS) and an electronic health record on up-to-date rates, overimmunization, and immunization record completeness for...
9.
Millar J, Reyes-Soffer G, Jumes P, Dunbar R, deGoma E, Baer A, et al.
J Clin Invest
. 2016 Apr;
126(4):1603-4.
PMID: 27035815
No abstract available.
10.
Teplow-Phipps R, Papadouka V, Benkel D, Holleran S, Ramakrishnan R, Rosenthal S, et al.
Am J Prev Med
. 2016 Apr;
51(2):161-169.
PMID: 27032464
Introduction: The human papillomavirus (HPV) vaccine was introduced for female adolescents prior to male adolescents. Understanding coverage patterns related to gender-specific recommendations and factors associated with early adoption and timely...